- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Digoxin, the cardiac glycoside in Lanoxin, is prescribed for selected cases of heart failure and certain heart-rate disorders. It strengthens heart contraction and slows electrical conduction through the atrioventricular node, which can help the heart pump more effectively and control an excessively rapid rate.
Product information
Digoxin is a purified cardiac glycoside associated historically with Digitalis plants. Modern treatment uses the purified active substance in a controlled pharmaceutical formulation. The botanical origin does not make the medicine suitable for self-treatment.
How it affects the body
Digoxin affects the heart in two main ways:
- It increases contractility, meaning the strength of each heart contraction.
- It slows conduction through the atrioventricular node, which can reduce the ventricular rate in some supraventricular arrhythmias.
Lanoxin does not function as a general heart tonic. It does not remove blocked coronary arteries or reverse the underlying cause of cardiomyopathy. The clinical benefit depends on the person’s rhythm, kidney function, electrolyte balance, age, body size and other medicines.
Digoxin can slow conduction through the atrioventricular node. This may help control the ventricular rate in atrial fibrillation or another supraventricular tachyarrhythmia when a clinician considers it appropriate.
The FDA prescribing information describes digoxin as a medicine requiring careful dose selection and monitoring because toxicity may occur when blood levels rise or the body becomes more sensitive to the drug [1].
Ingredients
Digoxin, the cardiac glycoside in Lanoxin, is prescribed for selected cases of heart failure and certain heart-rate disorders.
Cardiac Glycoside Classification
Digoxin is a purified cardiac glycoside associated historically with Digitalis plants. Modern treatment uses the purified active substance in a controlled pharmaceutical formulation. The botanical origin does not make the medicine suitable for self-treatment.
Dosage and administration
The amount of Lanoxin and the frequency of use depend on the purpose of treatment and are agreed with a doctor or pharmacist. Digoxin may be taken once daily in some regimens, while loading schedules and maintenance schedules differ between patients.
- Take Lanoxin at the prescribed time each day.
- Use the prescribed strength and route only.
- Keep the timing consistent in relation to meals.
- Do not change the dose because the pulse feels faster or slower.
- Do not combine different strengths to reproduce another dose.
- Do not double the next dose after a missed dose.
- Seek urgent medical help after an accidental extra dose, collapse, severe palpitations or marked confusion.
If a missed dose is remembered well before the next scheduled dose, the usual instruction may be to take it when remembered. If the next dose is near, the missed dose is generally skipped. The exact response depends on the schedule and timing, so a pharmacist or prescriber should provide the decision for the specific regimen.
Dose Individualisation
Kidney function has a major influence on digoxin exposure because the kidneys remove much of the drug from the body. Age, body size, thyroid status, potassium, magnesium, dehydration and interacting medicines also affect dose selection.
A medication review is useful after hospital discharge, a change in diuretic treatment, a kidney-function change or a new antibiotic prescription. Oral, injectable and paediatric digoxin presentations must not be converted by volume without a clinician’s calculation.
When not to use it
Lanoxin may be unsuitable or require specialist assessment if you have:
- Ventricular fibrillation or certain ventricular arrhythmias.
- Marked bradycardia or a significant atrioventricular conduction block without appropriate cardiac management.
- A known serious reaction to digoxin or another cardiac glycoside.
- Significant electrolyte disturbance that has not been corrected.
- Severe kidney impairment without a carefully adjusted regimen.
- A rhythm disorder in which slowing atrioventricular conduction could worsen the clinical situation.
These risks require clinical judgment. An ECG, kidney assessment and electrolyte testing may be needed before treatment or after a major health change.
When this is not for you
Lanoxin is not suitable for everyone. Some conditions rule it out, while others require a lower dose and closer monitoring. Kidney function affects exposure. ECG findings guide the decision. Electrolyte results also influence safety.
Older adults often clear digoxin more slowly and may show toxicity through confusion, appetite loss or weakness rather than dramatic heart symptoms. A standard previous dose may become unsuitable after dehydration, infection, hospitalisation or worsening kidney function.
Digoxin can slow the heart rate and atrioventricular conduction. This may be useful in selected supraventricular rhythms but harmful in some conduction disorders or ventricular arrhythmias. ECG assessment is central to deciding whether treatment is appropriate.
Possible side effects
Lanoxin side effects can be dose-related. Mild symptoms do not prove toxicity, yet new symptoms deserve attention because toxicity can affect the digestive system, nervous system, vision and heart rhythm.
| Possible dose-related effects | Symptoms needing urgent assessment |
|---|---|
| Nausea, vomiting, diarrhoea or appetite loss | Fainting, collapse or severe weakness |
| Dizziness, headache or confusion | New severe palpitations or marked slow pulse |
| Blurred or altered vision | Sustained irregular heartbeat or breathing difficulty |
Common Dose-Related Effects
Nausea, vomiting, diarrhoea, reduced appetite and dizziness are recognised adverse effects. They may reflect intolerance, excessive exposure or another illness. Persistent vomiting or diarrhoea can also lower potassium or magnesium and increase the risk of digoxin toxicity.
Do not stop prescribed treatment solely because of mild nausea without obtaining specific advice. The correct response depends on symptom severity, kidney function, the blood level when indicated and the ECG.
Visual and Neurological Toxicity Signals
Blurred vision, altered colour perception or yellow-tinted vision can occur with digoxin toxicity. Confusion, unusual drowsiness and weakness are also warning signs, especially in older adults.
A visual change is not diagnostic by itself. Stop driving and avoid machinery if vision or alertness changes, then obtain same-day medical advice.
Cardiac Emergency Symptoms
Digoxin toxicity can trigger dangerous arrhythmias. Fainting, collapse, severe palpitations, chest discomfort with marked weakness or a very slow or irregular pulse require urgent medical evaluation.
Therapeutic indications
Lanoxin is prescribed for selected patients with congestive heart failure, cardiomyopathy and some fast or irregular heart rhythms. Its role is determined by the diagnosed rhythm, cardiac function, kidney status and the rest of the treatment plan.
Heart Failure and Cardiomyopathy Support
In selected heart-failure patients, digoxin may improve symptoms and exercise tolerance by supporting cardiac contraction and reducing certain neurohormonal effects. It does not cure heart failure or reliably reverse cardiomyopathy. It also does not replace other guideline-directed treatments used for heart failure.
Doctors may consider Lanoxin when symptoms remain troublesome, when heart-rate control is needed, or when the full clinical picture makes digoxin suitable. The European Medicines Agency product information for digoxin describes the need to consider dose, renal function and patient-specific risk factors [2].
Heart-Rate Control in Selected Arrhythmias
Digoxin can slow conduction through the atrioventricular node. This may help control the ventricular rate in atrial fibrillation or another supraventricular tachyarrhythmia when a clinician considers it appropriate.
Coronary Artery Disease Context
Coronary heart disease, also called coronary artery disease, involves reduced blood flow through the coronary arteries. Lanoxin does not open narrowed arteries and does not prevent a heart attack. A person may have coronary artery disease and receive digoxin for a separate heart-failure or rate-control indication.
Comparison
Lanoxin and Generic Digoxin Substitution
Generic oral digoxin may contain the same active substance as Lanoxin, but substitution depends on the strength, formulation, route and local authorization. A branded oral pill, an injectable product and a paediatric formulation are not automatically interchangeable.
| Presentation | Main clinical distinction | Substitution approach |
|---|---|---|
| Lanoxin oral pills | Branded oral digoxin | Confirm strength and schedule |
| Generic oral digoxin | Same active substance may be present | Confirm pharmaceutical equivalence and dose |
| Injectable or paediatric digoxin | Different route or concentration | Never substitute without a clinician’s calculation |
A brand change can be clinically uneventful for one person and require follow-up for another. Confirm the active substance, strength and intended frequency before a switch. Serum monitoring may be appropriate when symptoms change, kidney function is unstable or the formulation changes.
Common mistakes
- Doubling the next dose after forgetting one.
- Choosing a different strength because the pill looks similar.
- Ignoring vomiting, diarrhoea or dehydration.
- Starting an antacid, fibre product or herbal supplement without a medicine review.
- Assuming a dose remains suitable after kidney function changes.
- Treating a slow pulse or palpitations by changing the schedule independently.
- Taking an extra dose because symptoms have not improved quickly.
- Forgetting to mention Lanoxin before a new prescription is issued.
What doctors say
In clinical practice, doctors use Lanoxin selectively. The benefit may be meaningful when heart-rate control is needed or when symptoms persist despite the wider heart-failure plan, yet the medicine demands more attention than many routine cardiovascular treatments.
A physician evaluates cardiac rhythm, blood pressure, kidney function, electrolytes, thyroid status, symptoms and interacting medicines together. A single normal blood result does not prove that the dose is suitable, and one symptom does not establish toxicity.
The main trade-off is clear: digoxin can support cardiac function and control heart rate, but its narrow therapeutic index leaves less room for unsupervised dose changes. Treatment should be reviewed after a new illness, a hospital admission, a substantial change in fluid intake or a new interacting medicine.
Common questions
What happens if Lanoxin is stopped, and does it need tapering?
Stopping Lanoxin can remove its support for heart-rate control or cardiac function, so symptoms may return or the underlying condition may become less controlled. The need for tapering depends on the reason for treatment, the rhythm, heart-failure status and the rest of the regimen. The FDA Lanoxin prescribing information from 2022 advises discussing discontinuation with the prescribing clinician rather than managing it independently. Arrange a planned change with the prescribing clinician, especially after long-term use.
How does Lanoxin differ from other heart-rate medicines?
Lanoxin contains digoxin, a cardiac glycoside that increases contractility and slows atrioventricular conduction. Other heart-rate medicines may work mainly by reducing sympathetic stimulation or by blocking calcium channels, so their effects and contraindications differ. WHO cardiovascular guidance published in 2024 supports choosing treatment according to the rhythm, cardiac function, kidney status and comorbidities. Lanoxin is not automatically interchangeable with another rate-control medicine.
Which condition rules Lanoxin out?
A significant ventricular arrhythmia, such as ventricular fibrillation, can rule out digoxin because slowing selected electrical pathways may worsen the situation. Marked bradycardia, important conduction block, uncorrected low potassium or low magnesium may also make treatment unsuitable or require correction first. FDA prescribing information from 2022 lists these rhythm and electrolyte concerns among the key safety considerations. The decision requires ECG and clinical assessment.
What is the best time of day to take Lanoxin?
The best time is the time assigned by the prescribed regimen, taken consistently each day. Consistency helps reduce missed doses and makes blood-level interpretation more useful when testing is required. NICE guidance from 2023 recommends consistent medicine use within an agreed treatment plan. Follow the agreed relationship with meals and keep antacids or fibre products separated according to the pharmacist’s specific instruction.
How long does a Lanoxin course last, and is long-term use acceptable?
Lanoxin may be used for an extended period when its benefits continue to outweigh its risks. Duration depends on heart failure, rhythm control, kidney function, age, symptoms, ECG findings and other treatments. The EMA SmPC for digoxin, published in 2021, describes ongoing monitoring and individualised prescribing. Long-term treatment is acceptable for selected patients, but the dose should be reassessed after major illness or medication changes.
What should happen if the expected result does not occur?
Do not take extra Lanoxin if heart-rate control or symptom improvement is inadequate. Persistent breathlessness, swelling, rapid palpitations, faintness or reduced exercise tolerance may indicate that the underlying condition or treatment plan needs review. The FDA label available in 2022 advises assessment of symptoms, rhythm, renal function and digoxin exposure rather than dose escalation based on symptoms alone. Urgent care is appropriate for collapse, severe palpitations, chest discomfort or severe breathing difficulty.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- U.S. Food and Drug Administration (2022). Lanoxin (digoxin) prescribing information
- European Medicines Agency (2021). Summary of Product Characteristics (SmPC) — digoxin